Amundi Atri Cure, Inc. Transaction History

Amundi

$275 Billion
Q1 2025

A detailed history of Amundi transactions in Atri Cure, Inc. stock. As of the latest transaction made, Amundi holds 254,934 shares of ATRC stock, worth $8.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

254,934

Previous 270,455 5.74%

Holding current value

$8.67 Million

Previous $8.27 Million 0.5%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$30.4 - $42.4 $471,838 - $658,090	-15,521 Reduced 5.74%	254,934 $8.22 Million
Q4 2024 Feb 07, 2025	SELL	$27.02 - $38.2 $848,238 - $1.2 Million	-31,393 Reduced 10.4%	270,455 $8.27 Million
Q3 2024 Nov 13, 2024	SELL	$20.34 - $29.5 $553,939 - $803,403	-27,234 Reduced 8.28%	301,848 $8.46 Million
Q2 2024 Aug 14, 2024	BUY	$19.86 - $29.09 $1.35 Million - $1.98 Million	68,089 Added 26.09%	329,082 $7.49 Million
Q1 2024 May 15, 2024	SELL	$28.21 - $37.78 $1.07 Million - $1.43 Million	-37,894 Reduced 12.68%	260,993 $7.94 Million
Q4 2023 Feb 14, 2024	BUY	$32.99 - $43.25 $2.97 Million - $3.9 Million	90,129 Added 43.17%	298,887 $10.7 Million
Q3 2023 Nov 14, 2023	BUY	$41.12 - $57.73 $533,038 - $748,353	12,963 Added 6.62%	208,758 $9.14 Million
Q2 2023 Aug 14, 2023	SELL	$40.44 - $49.6 $327,564 - $401,760	-8,100 Reduced 3.97%	195,795 $9.66 Million
Q1 2023 May 15, 2023	SELL	$35.87 - $47.22 $128,773 - $169,519	-3,590 Reduced 1.73%	203,895 $8.45 Million
Q4 2022 Feb 14, 2023	BUY	$33.48 - $47.45 $1.64 Million - $2.33 Million	49,010 Added 30.93%	207,485 $9.21 Million
Q3 2022 Nov 14, 2022	BUY	$38.25 - $52.62 $6.06 Million - $8.34 Million	158,475 New	158,475 $6.37 Million

Others Institutions Holding ATRC

# of Institutions

238

Shares Held

52M

Call Options Held

32.6K

Put Options Held

4.5K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.58B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account